PURPOSE: To evaluate the safety and efficacy of alteplase (TPA) for restoring function to occluded central venous catheters (CVCs). PATIENTS AND METHODS: The study design was a phase III, open-label, ...
LONDON (MarketWatch) -- Nuvelo Inc. said that Phase 2 clinical trial results shows that alfimeprase can quickly restore function to occluded central venous access devices. The results demonstrated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results